NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $79,009 | -68.3% | 112,404 | +1.8% | 0.04% | -66.9% |
Q4 2022 | $249,549 | +8.5% | 110,420 | +53.3% | 0.13% | +41.3% |
Q3 2022 | $230,000 | -14.8% | 72,018 | +1.5% | 0.09% | -8.0% |
Q2 2022 | $270,000 | +70.9% | 70,964 | +141.9% | 0.10% | +40.8% |
Q1 2022 | $158,000 | -60.1% | 29,334 | 0.0% | 0.07% | -52.7% |
Q4 2021 | $396,000 | -14.8% | 29,334 | +13.4% | 0.15% | -26.8% |
Q3 2021 | $465,000 | -4.1% | 25,864 | -8.4% | 0.20% | +3.0% |
Q2 2021 | $485,000 | -31.7% | 28,241 | -20.4% | 0.20% | -33.7% |
Q1 2021 | $710,000 | +21.0% | 35,476 | +2.8% | 0.30% | +23.0% |
Q4 2020 | $587,000 | +24.1% | 34,503 | +21.0% | 0.24% | -1.6% |
Q3 2020 | $473,000 | -21.8% | 28,525 | +9.2% | 0.25% | -13.6% |
Q2 2020 | $605,000 | +22.5% | 26,122 | -5.6% | 0.29% | +41.4% |
Q1 2020 | $494,000 | -23.8% | 27,666 | -7.8% | 0.20% | +91.5% |
Q4 2019 | $648,000 | +71.4% | 30,000 | +44.6% | 0.11% | +39.5% |
Q3 2019 | $378,000 | -56.6% | 20,742 | -15.2% | 0.08% | -58.5% |
Q2 2019 | $870,000 | +59.6% | 24,468 | +47.5% | 0.18% | +96.8% |
Q4 2018 | $545,000 | -35.6% | 16,594 | +19.6% | 0.09% | +6.9% |
Q3 2018 | $846,000 | +33.9% | 13,877 | +7.2% | 0.09% | -84.4% |
Q2 2018 | $632,000 | -60.4% | 12,942 | -13.8% | 0.56% | -59.6% |
Q1 2018 | $1,595,000 | +58.1% | 15,011 | -11.1% | 1.38% | +9.3% |
Q4 2017 | $1,009,000 | -25.1% | 16,891 | -69.9% | 1.27% | +595.6% |
Q3 2017 | $1,347,000 | +22.8% | 56,131 | 0.0% | 0.18% | +11.0% |
Q2 2017 | $1,097,000 | -45.0% | 56,131 | -34.0% | 0.16% | -53.8% |
Q1 2017 | $1,995,000 | +111.6% | 85,008 | +10.6% | 0.36% | +25.9% |
Q4 2016 | $943,000 | +32.6% | 76,834 | +85.7% | 0.28% | -18.0% |
Q3 2016 | $711,000 | +38.3% | 41,365 | +14.4% | 0.34% | -9.7% |
Q2 2016 | $514,000 | -2.3% | 36,153 | -5.5% | 0.38% | -47.4% |
Q1 2016 | $526,000 | -18.4% | 38,260 | 0.0% | 0.72% | -59.0% |
Q4 2015 | $645,000 | – | 38,260 | – | 1.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 1,828,400 | $89,281,000 | 6.61% |
Cormorant Asset Management, LP | 1,500,000 | $73,245,000 | 5.42% |
Camber Capital Management LP | 2,000,000 | $97,660,000 | 3.76% |
Rhenman & Partners Asset Management AB | 617,652 | $30,160,000 | 3.09% |
BRIDGER MANAGEMENT, LLC | 1,134,414 | $55,393,000 | 3.00% |
First Light Asset Management, LLC | 374,251 | $18,275,000 | 2.84% |
Gs Investments, Inc. | 54,000 | $2,636,820,000 | 1.97% |
SABBY MANAGEMENT, LLC | 241,922 | $11,813,000 | 1.82% |
QUANTRES ASSET MANAGEMENT Ltd | 50,000 | $2,441,000 | 1.41% |
Tibra Equities Europe Ltd | 173,183 | $8,457,000 | 1.27% |